Career Profile
Ms Margaret Phiri is a Pharmacist with 12 years experience, Lecturer, and PhD researcher with expertise in clinical pharmacy, pharmacovigilance, paediatric oncology, natural products research, nanotechnology, and pharmaceutical policy. She has extensive experience in teaching, research supervision, and hospital-based clinical practice, with a strong focus on improving medication safety, drug delivery efficiency, and therapeutic outcomes in resource-limited settings.
Her research interests include women’s health, oncology pharmacotherapy, nanotechnology-based drug delivery systems, herbal medicine safety, and health systems strengthening. She is actively engaged in producing policy-relevant, translational, and publishable research, particularly within the Zambian healthcare context.
Education Background
Educational Background
• Doctor of Philosophy (PhD) in Pharmacy (Industrial Pharmacy / Pharmaceutical Sciences) – University of Zambia (Ongoing)
• Master of Pharmaceutical Sciences (Pharmaceutical Analysis) – China Pharmaceutical University, China (2017–2020)
• Bachelor of Pharmacy (BPharm) – University of Zambia (2009–2014)
Publications
1. Li T, Li D, Xu X, Zhu Y, Phiri M, Ji S, Shu C, Ding L.
A simple injectable peptide-based hydrogel of Tanshinone IIA for antioxidant and anticoagulation.
Journal of Drug Delivery Science and Technology, 2020; 101532.
DOI: 10.1016/j.jddst.2020.101532
2. Phiri M, Li D, Li T, et al.
Intracellular pharmacokinetics of PARP inhibitors in breast and ovarian cancer cells and correlation to drug action: A review.
International Journal of Pharmacy and Pharmacology, 2020; 4:139.
DOI: 10.31531/2581-3080.1000139
3. Phiri M, Li D, Li T, Ji S, Ling T, Li X, Gao H, Ding L, Shu C.
Method development and validation for simultaneous determination of ebastine and its active metabolite carebastine in human plasma by LC–MS/MS and its application to a clinical pharmacokinetic study.
Biomedical Chromatography, 2020; e4904.
DOI: 10.1002/bmc.4904
4. Phiri M, Li D, Li T, et al.
Berberine versus sorafenib for the treatment of hepatocellular carcinoma.
International Journal of Biomedical Investigation, 2020; 3:125.
DOI: 10.31531/2581-4745.1000125
5. Kampamba M, Demba F, Mudenda S, et al., Phiri M, et al.
Medication administration omission errors: Frequency and causes during medication administration at Ndola Teaching Hospital, Zambia.
African Journal of Pharmacy and Pharmacology, 2021; 15(9):174–182.
DOI: 10.5897/AJPP2021.5264
6. Mwila K, Mudenda S, Kampamba M, et al., Phiri M, et al.
Factors affecting access to e-learning during the COVID-19 pandemic among rural-based pharmacy students in Zambia: A qualitative study.
Epidemiology Open Journal, 2021; 6(1):20–29.
DOI: 10.17140/EPOJ-6-124
7. Mwila K, Lufungulo E, Masaiti G, et al., Phiri M, Hikaambo C.
Abolishment of students’ meal allowances at the University of Zambia: Exploring alternative income sources, challenges and opportunities.
Creative Education, 2021; 12:2733–2751.
DOI: 10.4236/ce.2021.1211202
8. Mudenda S, Hikaambo C, Daka V, et al., Phiri M, et al.
Prevalence and factors associated with COVID-19 vaccine acceptance in Zambia: A web-based cross-sectional study.
Pan African Medical Journal, 2022; 41(112).
DOI: 10.11604/pamj.2022.41.112.31219
9. Hikaambo CN, Kaacha L, Mudenda S, et al., Phiri M, et al.
Phytochemical analysis and antibacterial activity of Azadirachta indica leaf extracts against Escherichia coli.
Pharmacology & Pharmacy, 2022; 13:1–10.
DOI: 10.4236/pp.2022.131001
10. Kampamba M, Maingaila V, Akapelwa TM, et al., Phiri M, Hikaambo C.
Knowledge, attitude and practices towards disposal of unused and expired medicines among students of private medical universities in Lusaka, Zambia.
Pharmacology & Pharmacy, 2022; 13:49–68.
DOI: 10.4236/pp.2022.132004